Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States

BACKGROUND: Pancreatic cancer is projected to become the second leading cause of cancer‐related deaths by 2030. Endoscopic retrograde cholangiopancreatography (ERCP) is recommended as first‐line therapy for biliary decompression in pancreatic cancer. The aim of our study was to characterize geograph...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavakkoli, Anna, Singal, Amit G., Waljee, Akbar K., Scheiman, James M., Murphy, Caitlin C., Pruitt, Sandi L., Xuan, Lei, Kwon, Richard S., Law, Ryan J., Elta, Grace H., Wright‐Slaughter, Phyllis, Valley, Thomas S., Kubiliun, Nisa, Nathan, Hari, Rubenstein, Joel H., Elmunzer, B. Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601581/
https://www.ncbi.nlm.nih.gov/pubmed/31087545
http://dx.doi.org/10.1002/cam4.2225

Ejemplares similares

Ejemplares similares